Tools

LEADER 01953nam a2200469 i 4500

001 on1041110256;

003 OCoLC;

005 20180619093218.0;

006 m o d f ;

007 cr mn|||||||||;

008 180619s2018 dcuab o f000 0 eng c;

035 a| (Sirsi) o1041110256;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 0967-L-02 (online);

086 0 a| J 24.32:F 36;

245 00 a| Fentanyl remains the most significant synthetic opioid threat and poses the greatest threat to the opioid user market in the United States.;

264 1 a| [Washington, D.C.] :b| DEA Strategic Intelligence Section,c| 2018.;

300 a| 1 online resource (11 pages) :b| color illustrations, color maps.;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

490 1 a| DEA intelligence brief;

500 a| "This product was prepared by the DEA Strategic Intelligence Section"--Page 11.;

500 a| "May 2018.";

500 a| "DEA-DCT-DIB-003-18.";

500 a| "Unclassified.";

500 a| CRDP Program record.;

588 a| Description based on online resource; title from PDF title page (Drug Enforcement Administration website, viewed June 19, 2018).;

650 0 a| Fentanylz| United States.=| ^A719975;

650 0 a| Fentanylx| Overdosez| United States.=| ^A719975;

650 0 a| Synthetic drugsz| United States.=| ^A471367;

650 0 a| Opioid abusez| United States.=| ^A1017318;

830 0 a| DEA intelligence brief.=| ^A1357814;

856 40 u| https://purl.fdlp.gov/GPO/gpo93751;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 4887667;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4887667-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 7/17/2018x| EDOCUMENTz| JERESOURCE;

Fentanyl remains the most significant synthetic opioid threat and poses the greatest threat to the opioid user market in the United States.

Other author	United States. Drug Enforcement Administration. Strategic Intelligence Section, issuing body.
Format	Electronic
Publication	[Washington, D.C.] : DEA Strategic Intelligence Section, 2018.
Description	1 online resource (11 pages) : color illustrations, color maps.
Supplemental Content	https://purl.fdlp.gov/GPO/gpo93751
Subjects	Fentanyl--United States. Fentanyl--Overdose. --United States. Synthetic drugs--United States. Opioid abuse--United States.

Series	DEA intelligence brief DEA intelligence brief. ^A1357814
General note	"This product was prepared by the DEA Strategic Intelligence Section"--Page 11.
General note	"May 2018."
General note	"DEA-DCT-DIB-003-18."
General note	"Unclassified."
General note	CRDP Program record.
Source of description	Description based on online resource; title from PDF title page (Drug Enforcement Administration website, viewed June 19, 2018).
GPO item number	0967-L-02 (online)
Govt. docs number	J 24.32:F 36

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Fentanyl remains the most significant synthetic opioid threat and poses the greatest threat to the opioid user market in the United States.

Click here for more information about this title

Availability